96 related articles for article (PubMed ID: 16414141)
1. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.
Cordelier P; Strayer DS
Virus Res; 2006 Jun; 118(1-2):87-97. PubMed ID: 16414141
[TBL] [Abstract][Full Text] [Related]
2. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 proprotein processing as a target for gene therapy.
Cordelier P; Zern MA; Strayer DS
Gene Ther; 2003 Mar; 10(6):467-77. PubMed ID: 12621451
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
5. Conditional expression of alpha1-antitrypsin delivered by recombinant SV40 vectors protects lymphocytes against HIV.
Cordelier P; Strayer DS
Gene Ther; 2003 Dec; 10(26):2153-6. PubMed ID: 14625571
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.
Cordelier P; Van Bockstaele E; Calarota SA; Strayer DS
Mol Ther; 2003 Jun; 7(6):801-10. PubMed ID: 12788654
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Exp Neurol; 2010 Jan; 221(1):231-45. PubMed ID: 19913017
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
BouHamdan M; Duan LX; Pomerantz RJ; Strayer DS
Gene Ther; 1999 Apr; 6(4):660-6. PubMed ID: 10476226
[TBL] [Abstract][Full Text] [Related]
9. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe.
Louboutin JP; Marusich E; Fisher-Perkins J; Dufour JP; Bunnell BA; Strayer DS
Gene Ther; 2011 Jul; 18(7):682-91. PubMed ID: 21368898
[TBL] [Abstract][Full Text] [Related]
11. Delivering genes to the organ-localized immune system: long-term results of direct intramarrow transduction.
Louboutin JP; Liu B; Chekmasova AA; Reyes BA; van Bockstaele EJ; Strayer DS
J Gene Med; 2007 Oct; 9(10):843-51. PubMed ID: 17694566
[TBL] [Abstract][Full Text] [Related]
12. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV.
Cordelier P; Morse B; Strayer DS
Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819
[TBL] [Abstract][Full Text] [Related]
13. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
14. Rat bone marrow progenitor cells transduced in situ by rSV40 vectors differentiate into multiple central nervous system cell lineages.
Louboutin JP; Liu B; Reyes BA; Van Bockstaele EJ; Strayer DS
Stem Cells; 2006 Dec; 24(12):2801-9. PubMed ID: 16960137
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
Goldstein H; Pettoello-Mantovani M; Anderson CM; Cordelier P; Pomerantz RJ; Strayer DS
J Infect Dis; 2002 May; 185(10):1425-30. PubMed ID: 11992277
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.
Yam P; Jensen M; Akkina R; Anderson J; Villacres MC; Wu J; Zaia JA; Yee JK
Mol Ther; 2006 Aug; 14(2):236-44. PubMed ID: 16647299
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cultured microglia that can be infected by HIV-1.
Albright AV; Shieh JT; O'Connor MJ; González-Scarano F
J Neurovirol; 2000 May; 6 Suppl 1():S53-60. PubMed ID: 10871766
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer using recombinant simian virus 40 viral vectors into mice bone marrow progenitor cells depressed the immunogenicity of keratinocyte stem cells.
Li W; Xu T; Wang JF; Wu XF; Li M; Lu PY
Transplant Proc; 2008 Dec; 40(10):3656-9. PubMed ID: 19100460
[TBL] [Abstract][Full Text] [Related]
19. Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55(Gag).
Albright AV; Vos RM; González-Scarano F
Virology; 2004 Aug; 325(2):328-39. PubMed ID: 15246272
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV replication: a powerful antiviral strategy by IFN-beta gene delivery in CD4+ cells.
Brule F; Khatissian E; Benani A; Bodeux A; Montagnier L; Piette J; Lauret E; Ravet E
Biochem Pharmacol; 2007 Sep; 74(6):898-910. PubMed ID: 17662695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
